AT&T Selected as Carrier to Connect Boston Scientific Cardiac Devices: Offering Physician and Patient Convenience

AT&T to Wirelessly Enable Boston Scientific Cardiac Device

DALLAS, Feb. 22, 2012 /PRNewswire/ -- Subject to its devices receiving necessary FDA approvals, Boston Scientific Corporation (NYSE: BSX) will have the capability to transmit implantable cardiac device data to physicians and other healthcare providers in North America across the AT&T wireless network in the future, AT&T* announced today.   

Using its extensive clinical expertise in remote patient monitoring, Boston Scientific plans to embed  AT&T wireless technology in its LATITUDE® Patient Management system, which will be utilized in the company's future generations of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators and pacemakers (CRT-Ds and CRT-Ps).

Boston Scientific's current remote monitoring system, LATITUDE®, allows physicians the ability to conduct remote follow-up of implantable cardiac device patients to monitor specific device information and heart health status.  The system can also detect clinical events between scheduled visits and send relevant data directly to a highly secure website that can be accessed by physicians.  Future wireless connectivity under the new agreement will allow the transmission of data to physicians from most locations without the need for landline-based technology.

"There is no question that the convergence of healthcare and mobile technology is happening today and offers limitless opportunities in the future.  We are very focused in helping drive this innovation.  Together with Boston Scientific, we will enable more convenient care for patients and more opportunities for physicians," said Glenn Lurie, president, emerging devices, AT&T Mobility.

"Physicians are asking for flexible connectivity solutions for remote monitoring systems that can improve efficiency," said Joe Fitzgerald, Senior Vice President and President of the Cardiac Rhythm Management Unit for Boston Scientific.  "Boston Scientific is pleased to collaborate with AT&T and benefit from its depth and breadth of cellular technology expertise to help physicians and their patients."

For the complete array of AT&T offerings, visit

*AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc.

About AT&T

AT&T Inc. (NYSE: T) is a premier communications holding company and one of the most honored companies in the world. Its subsidiaries and affiliates – AT&T operating companies – are the providers of AT&T services in the United States and around the world. With a powerful array of network resources that includes the nation's fastest mobile broadband network, AT&T is a leading provider of wireless, Wi-Fi, high speed Internet, voice and cloud-based services. A leader in mobile broadband and emerging 4G capabilities, AT&T also offers the best wireless coverage worldwide of any U.S. carrier, offering the most wireless phones that work in the most countries. It also offers advanced TV services under the AT&T U-verse® and AT&T | DIRECTV brands. The company's suite of IP-based business communications services is one of the most advanced in the world. In domestic markets, AT&T Advertising Solutions and AT&T Interactive are known for their leadership in local search and advertising.

Additional information about AT&T Inc. and the products and services provided by AT&T subsidiaries and affiliates is available at  This AT&T news release and other announcements are available at and as part of an RSS feed at Or follow our news on Twitter at @ATT.

© 2012 AT&T Intellectual Property. All rights reserved. Mobile broadband not available in all areas. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual Property and/or AT&T affiliated companies.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.  For more information, please visit:  

Cautionary Language Concerning Forward-Looking Statements

Information set forth in this news release contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results may differ materially. A discussion of factors that may affect future results is contained in AT&T's filings with the Securities and Exchange Commission. AT&T disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise.